Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra + LV5FU2 + Bevacizumab in mCRC
NCT02090101Phase 2Completed
- Sponsor
- Centre Georges-François Leclerc
- Start
- Oct 2014
- Primary completion
- Oct 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in metastatic colorectal cancer (mCRC), sponsored by Centre Georges-François Leclerc. Started Oct 2014; status: completed.
02
Drugs
anakinra
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02090101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090101.